Stockholders’ Equity (Details Narrative) - USD ($)					3 Months Ended		12 Months Ended
Stockholders’ Equity (Details Narrative) - USD ($)	Jan. 16, 2026	Dec. 19, 2025	Sep. 09, 2025	May 19, 2022	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Sep. 08, 2025	Jun. 16, 2023	May 09, 2022
Subsidiary, Sale of Stock [Line Items]
Preferred stock, issued					0		0
Dividends declared					$ 0		$ 0
Net issuance cost					41,000	$ 3,278,000
Equity Caoital					$ (614,000)		$ 3,508,000
Warrants rights to acquire					240,369
Shares issued
Sale of Stock, Price Per Share					$ 0.09
Share-based compensation expense					$ 438,000	$ 372,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount					$ 2,100,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition					2 years 6 months
2025 Directors Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Increase in the number of shares reserved for issuance			50,000	30,000
Shares issued					0
Shares authorized					60,000
Amended 2022 Directors Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Increase in shares for issuance									15,000
2022 Directors Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance								10,000
2025 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Increase in the number of shares reserved for issuance			300,000
Shares authorized					233,203
2022 Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Increase in shares for issuance										100,000
Common Stock, Capital Shares Reserved for Future Issuance								3,375
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Stock issued during the period, shares	549,105				163,900	11,315,000
Warrants rights to acquire	240,369
Warrants Exercise price	$ 0.00
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant share price					$ 0.16
Stock Purchase Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Equity Caoital	$ 10,000,000
At the Market Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Increase in the number of shares reserved for issuance					163,900
Sale of stock, consideration received on transaction					$ 40,000
Net issuance cost					$ 30,000
WestPark Capital, Inc [Member] \| At the Market Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Aggregate offering price		$ 5,300,000
Sale of stock, commission percentage		3.00%

ProPhase Labs, Inc. 10-Q